Guo L - Search Results

1

Digitoxin synergizes with sorafenib to inhibit hepatocelluar carcinoma cell growth without inhibiting cell migration.

Xiao Y, Yan W, Guo L, Meng C, Li B, Neves H, Chen PC, Li L, Huang Y, Kwok HF, Lin Y. Xiao Y, et al. Among authors: guo l. Mol Med Rep. 2017 Feb;15(2):941-947. doi: 10.3892/mmr.2016.6096. Epub 2016 Dec 30. Mol Med Rep. 2017. PMID: 28035421

2

Evaluating DAPK as a therapeutic target.

Huang Y, Chen L, Guo L, Hupp TR, Lin Y. Huang Y, et al. Among authors: guo l. Apoptosis. 2014 Feb;19(2):371-86. doi: 10.1007/s10495-013-0919-2. Apoptosis. 2014. PMID: 24305735 Review.

3

The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer.

Zhao D, Guo L, Neves H, Yuen HF, Zhang SD, McCrudden CM, Wen Q, Zhang J, Zeng Q, Kwok HF, Lin Y. Zhao D, et al. Among authors: guo l. Onco Targets Ther. 2015 Jul 13;8:1707-17. doi: 10.2147/OTT.S85899. eCollection 2015. Onco Targets Ther. 2015. PMID: 26203261 Free PMC article.

4

Targeting STAT1 in Both Cancer and Insulin Resistance Diseases.

Meng C, Guo LB, Liu X, Chang YH, Lin Y. Meng C, et al. Curr Protein Pept Sci. 2017;18(2):181-188. doi: 10.2174/1389203718666161117114735. Curr Protein Pept Sci. 2017. PMID: 27855602 Review.

5

DAPK1 as an independent prognostic marker in liver cancer.

Li L, Guo L, Wang Q, Liu X, Zeng Y, Wen Q, Zhang S, Kwok HF, Lin Y, Liu J. Li L, et al. Among authors: guo l. PeerJ. 2017 Jul 19;5:e3568. doi: 10.7717/peerj.3568. eCollection 2017. PeerJ. 2017. PMID: 28740751 Free PMC article.

6

β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer development.

Ling YM, Chen JY, Guo L, Wang CY, Tan WT, Wen Q, Zhang SD, Deng GH, Lin Y, Kwok HF. Ling YM, et al. Among authors: guo l. Sci Rep. 2017 Oct 17;7(1):13404. doi: 10.1038/s41598-017-13332-0. Sci Rep. 2017. PMID: 29042578 Free PMC article.

7

The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint.

Wang Q, Lin W, Tang X, Li S, Guo L, Lin Y, Kwok HF. Wang Q, et al. Among authors: guo l. Int J Mol Sci. 2017 Nov 27;18(12):2540. doi: 10.3390/ijms18122540. Int J Mol Sci. 2017. PMID: 29186904 Free PMC article. Review.

8

Targeting PD-L1 Protein: Translation, Modification and Transport.

Wei R, Guo L, Wang Q, Miao J, Kwok HF, Lin Y. Wei R, et al. Among authors: guo l. Curr Protein Pept Sci. 2019;20(1):82-91. doi: 10.2174/1389203719666180928105632. Curr Protein Pept Sci. 2019. PMID: 30264678 Review.

9

Death-associated protein kinase 1 suppresses hepatocellular carcinoma cell migration and invasion by upregulation of DEAD-box helicase 20.

Huang Y, Wang C, Li K, Ye Y, Shen A, Guo L, Chen P, Meng C, Wang Q, Yang X, Huang Z, Xing X, Lin Y, Liu X, Peng J, Lin Y. Huang Y, et al. Among authors: guo l. Cancer Sci. 2020 Aug;111(8):2803-2813. doi: 10.1111/cas.14499. Epub 2020 Jun 26. Cancer Sci. 2020. PMID: 32449268 Free PMC article.

10

Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment-Current Progress, Strategy, and Future Perspective.

Guo L, Wei R, Lin Y, Kwok HF. Guo L, et al. Front Immunol. 2020 Jul 7;11:1508. doi: 10.3389/fimmu.2020.01508. eCollection 2020. Front Immunol. 2020. PMID: 32733486 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20,059 results

Search Page